---
title: "Blood Borne Viruses Generic Medicines"
ocid: "ocds-r6ebe6-0000555794"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000555794"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000555794.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000555794.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2019-01-24"
---

# Blood Borne Viruses Generic Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000555794

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000555794)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000555794.json)

## Summary

The procurement process pertains to a Framework Agreement titled "Blood Borne Viruses Generic Medicines," initiated by The Common Services Agency, also known as NHS National Services Scotland, located in Edinburgh, UK. This procurement process falls under the health industry category and is currently at the Award stage. Key dates include the bid opening on 12 October 2018 and the signing of contracts on 24 December 2018. The process used was an open procedure, with delivery locations specified for health boards across NHS Scotland.

This tender presents significant opportunities for businesses involved in the pharmaceutical sector, particularly those supplying generic medicines, HIV treatments, and related healthcare products. Companies that can demonstrate compliance with specific regulatory standards, such as holding valid UK or EMA Marketing Authorisations and ISO certification, would be well-placed to compete. The diverse Lots within this Framework Agreement could attract a range of medium to large suppliers aiming to expand their market presence in the NHS supply chain.

## Notice

This Framework Agreement is for the supply of generic medicines used in the treatment and prevention of HIV and the treatment of Hepatitis B and Hepatitis C to health boards across NHS Scotland. The Goods have been split into three (3) Lots as follows: Lot 1 - the supply of generic HIV medicines, Hepatitis B medicines and Peginterferon Alfa-2a Lot 2 - the supply of Emtricitabine/Tenofovir Disoproxil Lot 3 - the supply of Ribavirin

### Lot Information

Ribavirin

The supply of ribavirin tablets to NHS Scotland. This Lot is awarded as an unranked multi supplier framework agreement.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Emtricitabine/Tenofovir Disoproxil

Supply of Emtricitabine/Tenofovir Disoproxil tablets to NHS Scotland. This Lot is awarded as a ranked multi supplier framework agreement. A maximum of five (5) suppliers are awarded to this Lot.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Generic medicines for the treatment of HIV, HBV and HCV

This Framework Agreement is for the supply of generic medicines used in the treatment of HIV, Hepatitis B and Hepatitis C to NHSScotland. This Lot is awarded as a single supplier framework agreement on a line by line basis.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343209 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Jan 2019 |
| Submission deadline | 12 Oct 2018 |
| Future notice date | Not specified |
| Award date | 24 Dec 2018 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £10,400,000 |
| Lots value | £10,350,000 |
| Awards value | Not specified |
| Contracts value | £6,091,464 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 10 |
| Supplier names | ACCORD HEALTHCARE; DR REDDY'S LABORATORIES (UK; GENERICS [UK] T/A MYLAN; GILEAD SCIENCES; GLENMARK PHARMACEUTICALS EUROPE; LUPIN (EUROPE; MILPHARM; ROCHE PRODUCTS; TEVA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Jan 2019 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343209
- 10 Sep 2018 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP331010

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP331010
  Blood Borne Viruses Generic Medicines - This Framework Agreement is for the supply of generic medicines used in the treatment and prevention of HIV and the treatment of Hepatitis B and Hepatitis C to health boards across NHS Scotland. The Goods have been split into three (3) Lots as follows: Lot 1 - the supply of generic HIV medicines, Hepatitis B medicines and Peginterferon Alfa-2a Lot 2 - the supply of Emtricitabine/Tenofovir Disoproxil Lot 3 - the supply of Ribavirin
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343209
  Blood Borne Viruses Generic Medicines - This Framework Agreement is for the supply of generic medicines used in the treatment and prevention of HIV and the treatment of Hepatitis B and Hepatitis C to health boards across NHS Scotland. The Goods have been split into three (3) Lots as follows: Lot 1 - the supply of generic HIV medicines, Hepatitis B medicines and Peginterferon Alfa-2a Lot 2 - the supply of Emtricitabine/Tenofovir Disoproxil Lot 3 - the supply of Ribavirin

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- http://www.publictendersscotland.publiccontractsscotland.gov.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000555794
- https://www.publiccontractsscotland.gov.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000555794. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000555794.json.